search
Back to results

Intraoperative Protective Mechanical Ventilation in Patients Requiring Emergency Abdominal Surgery (IMPROVE-2)

Primary Purpose

Emergency Abdominal Surgery, Mechanical Ventilation, General Anesthesia

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Driving-pressure-guided group
Low PEEP
Sponsored by
University Hospital, Clermont-Ferrand
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Emergency Abdominal Surgery focused on measuring Mechanical Ventilation, Lung-Protective Ventilation, Postoperative Pulmonary Complications, Postoperative morbidity

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult (≥18 years)
  • Patients requiring emergency (defined by the need to proceed to surgery within a few hours after diagnosis)
  • Laparoscopic or non-laparoscopic abdominal surgery under general anesthesia and with an expected duration of at least two hours

Exclusion Criteria:

  • Patients already receiving mechanical ventilation for more than 12 hours before enrollment
  • Intracranial hypertension
  • Chronic respiratory disease requiring oxygen therapy or mechanical ventilation at home
  • Undrained pneumothorax or subcutaneous emphysema
  • Patients for which death is deemed imminent and inevitable or patients with an underlying disease process with a life expectancy of less than 3 month
  • Body mass index (BMI) >40 kg/m2
  • Pregnant or breastfeeding women
  • Patients already enrolled in the IMPROVE-2 trial
  • Participation in a confounding trial with mortality or PRF as the main endpoint
  • Patient's or relative's refusal to participate
  • Guardianship or trusteeship patient
  • No affiliation to the Social Security system

Sites / Locations

  • University hospital
  • Hospital
  • University hospital
  • University Hospital
  • Hospital
  • University hospital
  • University hospital
  • University hospital
  • University hospital
  • University hospital
  • University hospital
  • University hospital
  • Assistance Publique-Hôpitaux de Marseille
  • Institut Paoli Calmette
  • University hospital
  • University hospital
  • University Hospital
  • University hospital
  • University hospital
  • Assistance Publique-Hôpitaux de Paris
  • University hospital
  • Hospital
  • University hospital
  • University hospital
  • University hospital
  • Hospital
  • University hospital
  • Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Low PEEP group

Driving-pressure-guided group

Arm Description

Patients will receive a PEEP level ≤5 cmH2O without recruitment maneuvers

Patients will receive PEEP levels individually set at the highest possible value (up to 15 cmH2O) providing a driving pressure (airway plateau pressure minus PEEP) lower than 13 cmH2O, in addition to recruitment maneuvers

Outcomes

Primary Outcome Measures

Postoperative respiratory failure
Composite criteria : - Failure to wean from the ventilator after surgery (Yes or No) - Requiring unplanned reintubation (Yes or No) - Curative non-invasive ventilation once extubated postoperatively (Yes or No) - Death (all cause of mortality) (Yes or No) If at least one of these 4 criteria is answered yes, the composite criterion (i.e. the primary outcome) will be answered yes

Secondary Outcome Measures

Postoperative pulmonary complications
Hypoxemia, pneumonia? development of acute respiratory distress syndrome (ARDS)
Postoperative extra-pulmonary complications
sepsis and septic shock, renal dysfunction
SOFA
Sequential-related Organ Failure Assessment
SOFA
Sequential-related Organ Failure Assessment
SOFA
Sequential-related Organ Failure Assessment
SOFA
Sequential-related Organ Failure Assessment
SOFA
Sequential-related Organ Failure Assessment
SOFA
Sequential-related Organ Failure Assessment
SOFA
Sequential-related Organ Failure Assessment
Ventilator-free days
The number of days alive and with unassisted breathing
Duration of invasive mechanical ventilation
Duration of invasive mechanical ventilation from randomization to first tracheal extubation
Total duration of mechanical ventilation
Total duration of mechanical ventilation (additive, for all épisodes)
Time to successful tracheal extubation
Absence of ventilatory support during the first 48 hours after extubation
Total volume of intraoperative fluids
Total volume of intraoperative fluids (crystalloids and colloids)
Median norepinephrine doses during surgery
µg/kg/min
Median phenylephrine doses during surgery
µg/kg/min
Median ephedrine doses during surgery
µg/kg/min
Intensive care unit (ICU)-free days
Intensive care unit (ICU)-free days
Duration of ICU stay
Duration of ICU stay
Duration of hospital stay
Duration of hospital stay
All-cause mortality
All-cause mortality
All-cause mortality
All-cause mortality
Time to death
Time to death (Days)
Hemodynamic instability
Hemodynamic instability ventilatory-related defined as a drop of arterial systolic pressure below 80 mmHg for more than 5 minutes not responding to treatment
Pneumothorax
Pneumothorax ventilatory-related

Full Information

First Posted
June 12, 2019
Last Updated
October 28, 2022
Sponsor
University Hospital, Clermont-Ferrand
search

1. Study Identification

Unique Protocol Identification Number
NCT03987789
Brief Title
Intraoperative Protective Mechanical Ventilation in Patients Requiring Emergency Abdominal Surgery
Acronym
IMPROVE-2
Official Title
Intraoperative Protective Mechanical Ventilation in Patients Requiring Emergency Abdominal Surgery: IMPROVE-2 Multicenter Prospective Randomized Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
February 18, 2021 (Actual)
Primary Completion Date
July 29, 2022 (Actual)
Study Completion Date
October 27, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of this study is to compare the effects of a strategy aimed at increasing alveolar recruitment (high PEEP levels adjusted according to driving pressure and recruitment maneuvers) with that of a strategy aimed at minimizing alveolar distension (low PEEP level without recruitment maneuver) on postoperative respiratory failure and mortality in patients receiving low VT ventilation during emergency abdominal surgery.
Detailed Description
Emergency abdominal surgery is associated with a high risk of morbidity and mortality. Postoperative pulmonary complications (PPCs) are the second most common surgical complication and adversely influence surgical morbidity. Postoperative respiratory failure (PRF) is one of the most serious pulmonary complication. Two hypotheses can be forward by the literature. First, a low VT lung protective ventilation in combination with a strategy aimed at minimizing alveolar distension by using low PEEP level (and without recruitment maneuver) could improve postoperative outcome while reducing the risk of hemodynamic alterations or, second, could increase the risk of PRF compared with a strategy aimed at increasing alveolar recruitment using higher PEEP level adjusted according to driving pressure in combination with recruitment maneuvers in adult patients undergoing emergency abdominal surgery. Given the uncertainties, and in order to determine the impact of lung protective ventilation strategies on clinical outcomes of high-risk surgical patients, a randomized trial is needed. Our primary hypothesis is that, during low VT ventilation, a strategy aimed at increasing alveolar recruitment by using high PEEP levels adjusted according to driving pressure in combination with recruitment maneuvers could be more effective at reducing PRF and mortality after emergency abdominal surgery than a strategy aimed at minimizing alveolar distension by using lower PEEP without recruitment maneuver. Given the number of patients for whom the question applies, the prevalence and the burden of PPCs, the study can have significant clinical importance and public health implications.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Emergency Abdominal Surgery, Mechanical Ventilation, General Anesthesia, Postoperative Morbidity
Keywords
Mechanical Ventilation, Lung-Protective Ventilation, Postoperative Pulmonary Complications, Postoperative morbidity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Multicenter, prospective, randomized, stratified, parallel-group clinical trial with blinded outcome assessment and concealed allocation of patients undergoing emergency abdominal surgery using low VT lung-protective ventilation to a strategy of minimal alveolar distension using low PEEP level or to a strategy aimed at increasing alveolar recruitment (higher PEEP level individually titrated to minimize the driving pressure in addition to recruitment maneuvers)
Masking
Outcomes Assessor
Masking Description
It will not be possible to mask the assigned ventilation strategy from the treating clinicians because they have an ethical responsibility to ensure patient safety during the emergency procedures. However, procedures will be put in place to minimize the possibility of bias arising because research staff becomes aware of trial group allocation. At each participating center, patients will be followed up for primary and secondary endpoints by members of the research staff who will be unaware of the trial group allocation. Information on whether the primary and secondary outcomes occur will be collected and entered into the electronic web-based case report form (eCRF) by trial or clinical trained personal (clinical research associate), blinded to the allocation group, under the supervision of the local principal investigator (PI) or designee who will also be unaware of the trial group allocation.
Allocation
Randomized
Enrollment
707 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Low PEEP group
Arm Type
Active Comparator
Arm Description
Patients will receive a PEEP level ≤5 cmH2O without recruitment maneuvers
Arm Title
Driving-pressure-guided group
Arm Type
Experimental
Arm Description
Patients will receive PEEP levels individually set at the highest possible value (up to 15 cmH2O) providing a driving pressure (airway plateau pressure minus PEEP) lower than 13 cmH2O, in addition to recruitment maneuvers
Intervention Type
Other
Intervention Name(s)
Driving-pressure-guided group
Intervention Description
Patients will receive PEEP levels individually set at the highest possible value (up to 15 cmH2O) providing a driving pressure (airway plateau pressure minus PEEP) lower than 13 cmH2O, in addition to recruitment maneuvers.
Intervention Type
Other
Intervention Name(s)
Low PEEP
Intervention Description
Patients will receive a PEEP level ≤5 cmH2O without recruitment maneuvers
Primary Outcome Measure Information:
Title
Postoperative respiratory failure
Description
Composite criteria : - Failure to wean from the ventilator after surgery (Yes or No) - Requiring unplanned reintubation (Yes or No) - Curative non-invasive ventilation once extubated postoperatively (Yes or No) - Death (all cause of mortality) (Yes or No) If at least one of these 4 criteria is answered yes, the composite criterion (i.e. the primary outcome) will be answered yes
Time Frame
Hospital discharge - Up to day 30
Secondary Outcome Measure Information:
Title
Postoperative pulmonary complications
Description
Hypoxemia, pneumonia? development of acute respiratory distress syndrome (ARDS)
Time Frame
Day 30
Title
Postoperative extra-pulmonary complications
Description
sepsis and septic shock, renal dysfunction
Time Frame
Day 30
Title
SOFA
Description
Sequential-related Organ Failure Assessment
Time Frame
Day 1
Title
SOFA
Description
Sequential-related Organ Failure Assessment
Time Frame
Day 2
Title
SOFA
Description
Sequential-related Organ Failure Assessment
Time Frame
Day 3
Title
SOFA
Description
Sequential-related Organ Failure Assessment
Time Frame
Day 4
Title
SOFA
Description
Sequential-related Organ Failure Assessment
Time Frame
Day 5
Title
SOFA
Description
Sequential-related Organ Failure Assessment
Time Frame
Day 6
Title
SOFA
Description
Sequential-related Organ Failure Assessment
Time Frame
Day 7
Title
Ventilator-free days
Description
The number of days alive and with unassisted breathing
Time Frame
Day 30
Title
Duration of invasive mechanical ventilation
Description
Duration of invasive mechanical ventilation from randomization to first tracheal extubation
Time Frame
Up to Day 30
Title
Total duration of mechanical ventilation
Description
Total duration of mechanical ventilation (additive, for all épisodes)
Time Frame
Up to Day 30
Title
Time to successful tracheal extubation
Description
Absence of ventilatory support during the first 48 hours after extubation
Time Frame
48 hours
Title
Total volume of intraoperative fluids
Description
Total volume of intraoperative fluids (crystalloids and colloids)
Time Frame
Day 1
Title
Median norepinephrine doses during surgery
Description
µg/kg/min
Time Frame
Day 1
Title
Median phenylephrine doses during surgery
Description
µg/kg/min
Time Frame
Day 1
Title
Median ephedrine doses during surgery
Description
µg/kg/min
Time Frame
Day 1
Title
Intensive care unit (ICU)-free days
Description
Intensive care unit (ICU)-free days
Time Frame
Day 30
Title
Duration of ICU stay
Description
Duration of ICU stay
Time Frame
Up to day 90
Title
Duration of hospital stay
Description
Duration of hospital stay
Time Frame
Up to day 90
Title
All-cause mortality
Description
All-cause mortality
Time Frame
Day 30
Title
All-cause mortality
Description
All-cause mortality
Time Frame
Day 90
Title
Time to death
Description
Time to death (Days)
Time Frame
Up to 90 days
Title
Hemodynamic instability
Description
Hemodynamic instability ventilatory-related defined as a drop of arterial systolic pressure below 80 mmHg for more than 5 minutes not responding to treatment
Time Frame
Up to day 30
Title
Pneumothorax
Description
Pneumothorax ventilatory-related
Time Frame
Up to day 30

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult (≥18 years) Patients requiring emergency (defined by the need to proceed to surgery within a few hours after diagnosis) Laparoscopic or non-laparoscopic abdominal surgery under general anesthesia and with an expected duration of at least two hours Exclusion Criteria: Patients already receiving mechanical ventilation for more than 12 hours before enrollment Intracranial hypertension Chronic respiratory disease requiring oxygen therapy or mechanical ventilation at home Undrained pneumothorax or subcutaneous emphysema Patients for which death is deemed imminent and inevitable or patients with an underlying disease process with a life expectancy of less than 3 month Body mass index (BMI) >40 kg/m2 Pregnant or breastfeeding women Patients already enrolled in the IMPROVE-2 trial Participation in a confounding trial with mortality or PRF as the main endpoint Patient's or relative's refusal to participate Guardianship or trusteeship patient No affiliation to the Social Security system
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Emmanuel Futier
Organizational Affiliation
CHU de Clermont-Ferrand
Official's Role
Principal Investigator
Facility Information:
Facility Name
University hospital
City
Angers
Country
France
Facility Name
Hospital
City
Annecy
Country
France
Facility Name
University hospital
City
Besancon
Country
France
Facility Name
University Hospital
City
Bordeaux
Country
France
Facility Name
Hospital
City
Chalon-sur-Saône
Country
France
Facility Name
University hospital
City
Clermont-Ferrand
Country
France
Facility Name
University hospital
City
Dijon
Country
France
Facility Name
University hospital
City
Grenoble
Country
France
Facility Name
University hospital
City
Le Mans
Country
France
Facility Name
University hospital
City
Lille
Country
France
Facility Name
University hospital
City
Lyon
Country
France
Facility Name
University hospital
City
Marseile
Country
France
Facility Name
Assistance Publique-Hôpitaux de Marseille
City
Marseille
Country
France
Facility Name
Institut Paoli Calmette
City
Marseille
Country
France
Facility Name
University hospital
City
Marseille
Country
France
Facility Name
University hospital
City
Montpellier
Country
France
Facility Name
University Hospital
City
Nantes
Country
France
Facility Name
University hospital
City
Nice
Country
France
Facility Name
University hospital
City
Nîmes
Country
France
Facility Name
Assistance Publique-Hôpitaux de Paris
City
Paris
Country
France
Facility Name
University hospital
City
Point A Pitre
Country
France
Facility Name
Hospital
City
Périgueux
Country
France
Facility Name
University hospital
City
Rennes
Country
France
Facility Name
University hospital
City
Saint-Etienne
Country
France
Facility Name
University hospital
City
Strasbourg
Country
France
Facility Name
Hospital
City
Suresnes
Country
France
Facility Name
University hospital
City
Toulouse
Country
France
Facility Name
Hospital
City
Valenciennes
Country
France

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The French National Data Safety Authority (CNIL) forbids making data freely available without prior agreement. Thus, the data underlying study findings cannot be made freely available because of ethical and legal restrictions. However, individual participant data underlying the results reported in the manuscript (text, tables, figures, and appendices) can be obtained after deidentification. Data can be obtained upon request from the IMPROVE-2 steering committee. Readers may contact: efutier@chu-clermontferrand.fr to request the data. The data cannot be freely available for the reasons mentioned above. Data access can be only possible after scientific assessment and data sharing agreement, detailing the type of data requested. This data sharing agreement has to be signed between applicants and the sponsor, Clermont-Ferrand University Hospital.
IPD Sharing Time Frame
Beginning 6 months following article publication. No end date
IPD Sharing Access Criteria
. Data can be obtained upon request from the IMPROVE-2 steering committee. Readers may contact: efutier@chu-clermontferrand.fr to request the data.
Citations:
PubMed Identifier
35523498
Citation
Khaled L, Godet T, Jaber S, Chanques G, Asehnoune K, Bourdier J, Araujo L, Futier E, Pereira B. Intraoperative protective mechanical ventilation in patients requiring emergency abdominal surgery: the multicentre prospective randomised IMPROVE-2 study protocol. BMJ Open. 2022 May 6;12(5):e054823. doi: 10.1136/bmjopen-2021-054823.
Results Reference
derived

Learn more about this trial

Intraoperative Protective Mechanical Ventilation in Patients Requiring Emergency Abdominal Surgery

We'll reach out to this number within 24 hrs